ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, was named one of America's 100 Most Trustworthy Companies by Forbes. Of the approximately 8,500 public companies reviewed to compile the list, ZOLL ranked 25th and was among only three Medical Equipment & Supplies companies listed.

The research, conducted by Audit Integrity for Forbes, was based on corporate governance best practices. In the independent firm's judgment, companies making this list "showed the highest degree of accounting transparency and fair dealing to stake-holders during 2006." (http://www.forbes.com/leadership/2007/03/26/companies-accounting- governance-lead-cx_pm_0327trusty.html)

?We believe strongly in the importance of providing shareholder value,? said Richard A. Packer, ZOLL's President and Chief Executive Officer. ?Inclusion on the Forbes list of most trustworthy companies recognizes our efforts to show the highest degree of accounting reliability over financial reporting. It is also indicative of our commitment to save lives by engineering and manufacturing the world's most advanced, most efficacious resuscitation devices.?

ZOLL's pioneering medical products for treating sudden cardiac arrest, the world's number one cause of death, have been instrumental in improving the quality of CPR. They include:

  • AutoPulse®, an innovative CPR ?machine? that automates chest compressions
  • Defibrillators containing Real CPR Help?, adding auditory and visual real-time feedback on the rate and depth of chest compressions to encourage high-quality CPR, which maximizes blood flow
  • LifeVest®, a wearable external defibrillator
  • See-Thru CPR?*, a new technology that helps to minimize interruptions in CPR ? one of the key recommendations of the American Heart Association's Guidelines for Advanced Life Support

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.

Certain statements contained in this press release regarding matters that are not historical facts are ?forward-looking? statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL's ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled ?Risk Factors? in ZOLL's Quarterly Report on Form 10-Q, which was filed with the SEC on May 11, 2007.

* 510(k) pending on AED Pro®

©2007 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. Real CPR Help and See-Thru CPR are trademarks of ZOLL Medical Corporation. AutoPulse, LifeVest, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.